NuCana Market Capitalization from 2010 to 2025
| NCNA Stock | USD 0.97 0.04 4.30% |
Check NuCana PLC financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among NuCana PLC's main balance sheet or income statement drivers, such as Discontinued Operations of 0.0, Interest Expense of 1.2 M or Selling General Administrative of 5.5 M, as well as many indicators such as Price To Sales Ratio of 551, Dividend Yield of 0.0 or PTB Ratio of 0.9. NuCana financial statements analysis is a perfect complement when working with NuCana PLC Valuation or Volatility modules.
NuCana | Market Capitalization |
Latest NuCana PLC's Market Capitalization Growth Pattern
Below is the plot of the Market Cap of NuCana PLC over the last few years. It is NuCana PLC's Market Cap historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in NuCana PLC's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 3.81 M | 10 Years Trend |
|
Market Cap |
| Timeline |
NuCana Market Capitalization Regression Statistics
| Arithmetic Mean | 208,164,588 | |
| Geometric Mean | 124,910,370 | |
| Coefficient Of Variation | 69.41 | |
| Mean Deviation | 130,092,337 | |
| Median | 320,040,331 | |
| Standard Deviation | 144,490,504 | |
| Sample Variance | 20877.5T | |
| Range | 391.7M | |
| R-Value | (0.87) | |
| Mean Square Error | 5598.7T | |
| R-Squared | 0.75 | |
| Significance | 0.000015 | |
| Slope | (26,277,996) | |
| Total Sum of Squares | 313162.6T |
NuCana Market Capitalization History
About NuCana PLC Financial Statements
NuCana PLC stakeholders use historical fundamental indicators, such as NuCana PLC's Market Capitalization, to determine how well the company is positioned to perform in the future. Although NuCana PLC investors may analyze each financial statement separately, they are all interrelated. For example, changes in NuCana PLC's assets and liabilities are reflected in the revenues and expenses on NuCana PLC's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in NuCana PLC. Please read more on our technical analysis and fundamental analysis pages.
NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of products for the treatment of cancer. NuCana plc was incorporated in 1997 and is headquartered in Edinburgh, the United Kingdom. Nucana Plc is traded on NASDAQ Exchange in the United States.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether NuCana PLC offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of NuCana PLC's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Nucana Plc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Nucana Plc Stock:Check out the analysis of NuCana PLC Correlation against competitors. For information on how to trade NuCana Stock refer to our How to Trade NuCana Stock guide.You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NuCana PLC. If investors know NuCana will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NuCana PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of NuCana PLC is measured differently than its book value, which is the value of NuCana that is recorded on the company's balance sheet. Investors also form their own opinion of NuCana PLC's value that differs from its market value or its book value, called intrinsic value, which is NuCana PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NuCana PLC's market value can be influenced by many factors that don't directly affect NuCana PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NuCana PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if NuCana PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NuCana PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.